MANNKIND CORP Production Related Impairments or Charges
MANNKIND CORP (MNKD) reported Production Related Impairments or Charges of $2.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductionRelatedImpairmentsOrCharges · last filed 2026-08-05
- MANNKIND CORP production related impairments or charges for the quarter ending 2026-06-30 was $1.37M, a 70.17% decline year-over-year.
- MANNKIND CORP production related impairments or charges for the quarter ending 2026-03-31 was $1.07M, a 130.69% increase year-over-year.
- MANNKIND CORP production related impairments or charges for the quarter ending 2025-12-31 was $2.06M, a 5.96% increase year-over-year.
- MANNKIND CORP production related impairments or charges for the quarter ending 2025-09-30 was $3.30M, a 1000.00% increase year-over-year.
- MANNKIND CORP production related impairments or charges for fiscal 2025 was $10.40M, a 169.70% increase from fiscal 2024.
- MANNKIND CORP production related impairments or charges for fiscal 2024 was $3.85M, a 15.72% decline from fiscal 2023.
- MANNKIND CORP production related impairments or charges for fiscal 2023 was $4.57M, a 107.72% increase from fiscal 2022.
- MANNKIND CORP production related impairments or charges for fiscal 2022 was $2.20M, a 15.77% increase from fiscal 2021.
| Period end | Production Related Impairments or Charges 3 month | Production Related Impairments or Charges 6 month | Production Related Impairments or Charges 6 month as first filed | Production Related Impairments or Charges 9 month | Production Related Impairments or Charges 9 month as first filed | Production Related Impairments or Charges 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.45M 10-Q · filed 2026-08-05 | $4.51M derived: sum of 3 quarters · filed 2026-08-05 | $7.81M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-06 | $3.14M derived: sum of 2 quarters · filed 2026-05-06 | $6.44M derived: sum of 3 quarters · filed 2026-05-06 | $11.04M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2025-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.36M derived: sum of 2 quarters · filed 2026-02-26 | $9.96M derived: sum of 3 quarters · filed 2026-02-26 | $10.40M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $3.30M 10-Q · filed 2025-11-05 | $7.90M derived: sum of 2 quarters · filed 2025-11-05 | $8.34M 10-Q · filed 2025-11-05 | $10.31M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2025-06-30 | $4.60M 10-Q · filed 2025-08-06 | $5.06M 10-Q · filed 2026-08-05 | $7.01M derived: sum of 3 quarters · filed 2026-05-06 | $7.31M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2025-03-31 | $466.00K 10-Q · filed 2026-05-06 | $2.41M derived: sum of 2 quarters · filed 2026-05-06 | $2.71M derived: sum of 3 quarters · filed 2026-05-06 | $3.31M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.25M derived: sum of 2 quarters · filed 2026-02-26 | $2.85M derived: sum of 3 quarters · filed 2026-02-26 | $3.85M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-05 | $900.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.91M 10-Q · filed 2025-11-05 | $2.84M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $600.00K 10-Q · filed 2025-08-06 | $1.62M 10-Q · filed 2025-08-06 | $2.54M derived: sum of 3 quarters · filed 2026-02-26 | $2.84M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $1.03M 10-Q · filed 2025-05-08 | $1.94M derived: sum of 2 quarters · filed 2026-02-26 | $2.24M derived: sum of 3 quarters · filed 2026-02-26 | $3.24M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.22M derived: sum of 2 quarters · filed 2026-02-26 | $2.21M derived: sum of 3 quarters · filed 2026-02-26 | $4.57M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $300.00K 10-Q · filed 2024-11-07 | $1.30M derived: sum of 2 quarters · filed 2024-11-07 | $3.66M 10-Q · filed 2024-11-07 | $4.55M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $1.00M 10-Q · filed 2024-08-07 | $3.36M 10-Q · filed 2024-08-07 | $4.25M derived: sum of 3 quarters · filed 2025-02-26 | $5.15M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $2.42M 10-Q · filed 2024-05-08 | $3.25M derived: sum of 2 quarters · filed 2025-02-26 | $4.15M derived: sum of 3 quarters · filed 2025-02-26 | $4.65M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $834.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.73M derived: sum of 2 quarters · filed 2025-02-26 | $2.23M derived: sum of 3 quarters · filed 2025-02-26 | $2.20M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $900.00K 10-Q · filed 2023-11-07 | $1.40M derived: sum of 2 quarters · filed 2023-11-07 | $1.37M 10-Q · filed 2023-11-07 | $3.30M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-07 | $451.00K 10-Q · filed 2023-08-07 | $2.40M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $1.90M derived: sum of 2 quarters · filed 2024-02-27 | $1.90M derived: sum of 3 quarters · filed 2024-02-27 | $1.90M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.90M derived: sum of 2 quarters · filed 2024-02-27 | $1.90M derived: sum of 3 quarters · filed 2024-02-27 | $1.90M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $496.00K 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $496.00K 10-Q · filed 2021-11-09 | $496.00K derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 | $496.00K 10-Q · filed 2021-08-11 | $496.00K derived: sum of 3 quarters · filed 2021-05-12 | $496.00K derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2020-03-31 | $496.00K 10-Q · filed 2021-05-12 | $496.00K derived: sum of 2 quarters · filed 2021-05-12 | $496.00K derived: sum of 3 quarters · filed 2021-05-12 | $496.00K derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | $420.00K derived: sum of 4 quarters · filed 2020-11-04 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $420.00K derived: sum of 3 quarters · filed 2020-08-05 | $1.42M derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | $420.00K derived: sum of 2 quarters · filed 2020-05-06 | $1.42M derived: sum of 3 quarters · filed 2020-05-06 | $1.62M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.42M derived: sum of 2 quarters · filed 2020-02-25 | $1.62M derived: sum of 3 quarters · filed 2020-02-25 | $2.21M 10-K · filed 2020-02-25 | ||
| 2018-09-30 | $1.00M 10-Q · filed 2019-11-08 | $1.20M derived: sum of 2 quarters · filed 2019-11-08 | $1.79M 10-Q · filed 2019-11-08 | $2.98M derived: sum of 4 quarters · filed 2019-11-08 | ||
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-07 | $779.00K 10-Q · filed 2019-08-07 | $1.98M derived: sum of 3 quarters · filed 2019-08-07 | $2.28M derived: sum of 4 quarters · filed 2019-08-07 | ||
| 2018-03-31 | $602.00K 10-Q · filed 2019-05-07 | $1.78M derived: sum of 2 quarters · filed 2019-05-07 | $2.08M derived: sum of 3 quarters · filed 2019-05-07 | $3.58M derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.48M derived: sum of 2 quarters · filed 2019-02-26 | $2.98M derived: sum of 3 quarters · filed 2019-02-26 | $2.97M 10-K · filed 2019-02-26 | ||
| 2017-09-30 | $300.00K 10-Q · filed 2017-11-07 | $1.80M derived: sum of 2 quarters · filed 2018-08-02 | $1.79M 10-Q · filed 2018-11-01 | $1.80M 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $1.50M 10-Q · filed 2018-08-02 | $1.46M 10-Q · filed 2018-08-02 | $1.50M 10-Q · filed 2017-08-07 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 | |||||
| 2015-12-31 | $36.10M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |